Skip to main content
TechReportedMedium
5.0

Lotte Biologics completes Incheon plant, targets global CDMO expansion

Lotte Biologics finished building its biopharmaceutical production facility in Incheon, South Korea, signaling capacity expansion and a push into the global contract development and manufacturing organization (CDMO) market. The move intensifies competition with established players in the biomanufacturing space. Financial terms and capacity details remain undisclosed.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

Yonhap EN2 days agoKRengCredibility 17%View source

Score Breakdown

Mosaic Score5.0
Model confidence0.7
Significance0.5
Source credibility0.2

Intelligence Tags

Locations

IncheonSeoul

Entities

South Koreacountry
Source

Related signals

8 found